SCHEDULE 13G/A 0001079973-24-000852 0001890802 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 11/14/2025 0000744452 Applied DNA Sciences Inc. 03815U607 50 Health Sciences Drive Stony Brook NY 11790 Rule 13d-1(c) S.H.N. Financial Investments Ltd. L3 155586.00 0.00 155586.00 0.00 155586.00 N 3.4 FI Applied DNA Sciences Inc. 50 Health Sciences Drive, Stony Brook, NY 11790 S.H.N. Financial Investments Ltd. Herzliya Hills Arik Einstein 3, Israel, 4610301 Israel Y 155,586 This amendment refers to a Schedule 13G filed with the Securities and Exchange Commission on June 7, 2024, covering 1,013,807 Common Shares purchased on May 28, 2024. The amounts in Row (5), (7) and (9) represent 152,669 Series A Warrants and 2,917 Series C Warrants, each to purchase shares of Common Stock of the Issuer. The percentage set forth on Row (11) of the cover page for the reporting person is based on 4,354,782 shares of Common Stock outstanding as of October 31, 2025, based on the Issuer's Preliminary Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on October 30, 2025. Nir Shamir is the Chief Executive Officer of the Reporting Person. As such, Mr. Shamir may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the securities described herein. To the extent Mr. Shamir is deemed to beneficially own such securities, Mr. Shamir disclaims beneficial ownership of these securities for all other purposes. 3.4% 155,586 0 155,586 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. S.H.N. Financial Investments Ltd. /s/ Nir Shamir 11/14/2025